Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Report

Global and Region Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：151
  • REPORT CODE：GMM880107
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • DTaP (also DTPa and TDaP) is a combined vaccine against diphtheria, tetanus, and pertussis, in which the pertussis component is acellular. This is in contrast to whole-cell, inactivated DTP (aka DTwP). The acellular vaccine uses selected antigens of the pertussis pathogen to induce immunity. Because it uses fewer antigens than the whole cell vaccines, it is considered safer, but it is also more expensive. Recent research suggests that the DTP vaccine is more effective than DTaP in conferring immunity; this is because DTaP's narrower antigen base is less effective against current pathogen strains.

    The report details the trend, potential and market size of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccinemarket, defines the market attractiveness level of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine industry, describes the types of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market, the applications of major players and the market size, and deeply analyzes the current situation of the global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market and the development prospects and opportunities of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market in Chapter 13.

    By Player:

    • Lanzhou Institute of Biological Products Co, Ltd

    • Pfizer Inc

    • GlaxoSmithKline

    • Seqirus

    • AstraZeneca

    • Protein Sciences Corporation

    • Astellas Pharma US, Inc

    • Sanofi Pasteur

    • Johnson & Johnson

    • Novartis AG

    • Emergent BioSolutions Inc

    • Merck Sharp & Dohme Corp

    By Type:

    • Immune DTaP Vaccine

    • Therapy DTaP Vaccine

    By End-User:

    • Adult

    • Pediatric

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Analysis and Outlook to 2022

    • 7.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)

    • 7.2 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)

    • 7.3 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)

    • 7.4 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)

    • 7.5 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)

    • 7.6 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)

    • 7.7 South Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)

    8 Region and Country-wise Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Analysis and Outlook to 2028

    • 8.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)

    • 8.2 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)

    • 8.3 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)

    • 8.4 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)

    • 8.5 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)

    • 8.6 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)

    • 8.7 South Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)

    9 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Immune DTaP Vaccine Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Therapy DTaP Vaccine Consumption and Growth Rate (2017-2022)

    • 9.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Adult Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Pediatric Consumption and Growth Rate (2017-2022)

    10 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Outlook by Types and Applications to 2028

    • 10.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Immune DTaP Vaccine Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Therapy DTaP Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Adult Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Pediatric Consumption Forecast and Growth Rate (2022-2028)

    11 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Competitive Analysis

    • 14.1 Lanzhou Institute of Biological Products Co, Ltd

      • 14.1.1 Lanzhou Institute of Biological Products Co, Ltd Company Details

      • 14.1.2 Lanzhou Institute of Biological Products Co, Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Lanzhou Institute of Biological Products Co, Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product and Service

    • 14.2 Pfizer Inc

      • 14.2.1 Pfizer Inc Company Details

      • 14.2.2 Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product and Service

    • 14.3 GlaxoSmithKline

      • 14.3.1 GlaxoSmithKline Company Details

      • 14.3.2 GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product and Service

    • 14.4 Seqirus

      • 14.4.1 Seqirus Company Details

      • 14.4.2 Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product and Service

    • 14.5 AstraZeneca

      • 14.5.1 AstraZeneca Company Details

      • 14.5.2 AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product and Service

    • 14.6 Protein Sciences Corporation

      • 14.6.1 Protein Sciences Corporation Company Details

      • 14.6.2 Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product and Service

    • 14.7 Astellas Pharma US, Inc

      • 14.7.1 Astellas Pharma US, Inc Company Details

      • 14.7.2 Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product and Service

    • 14.8 Sanofi Pasteur

      • 14.8.1 Sanofi Pasteur Company Details

      • 14.8.2 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product and Service

    • 14.9 Johnson & Johnson

      • 14.9.1 Johnson & Johnson Company Details

      • 14.9.2 Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product and Service

    • 14.10 Novartis AG

      • 14.10.1 Novartis AG Company Details

      • 14.10.2 Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product and Service

    • 14.11 Emergent BioSolutions Inc

      • 14.11.1 Emergent BioSolutions Inc Company Details

      • 14.11.2 Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product and Service

    • 14.12 Merck Sharp & Dohme Corp

      • 14.12.1 Merck Sharp & Dohme Corp Company Details

      • 14.12.2 Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine

    • Figure Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Picture

    • Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by Country (2017-2022)

    • Figure United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immune DTaP Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Therapy DTaP Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Adult Consumption and Growth Rate (2017-2022)

    • Figure Global Pediatric Consumption and Growth Rate (2017-2022)

    • Figure Global Immune DTaP Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Therapy DTaP Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adult Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pediatric Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Export by Region (Top 5 Countries) (2017-2028)

    • Table Lanzhou Institute of Biological Products Co, Ltd (Foundation Year, Company Profile and etc.)

    • Table Lanzhou Institute of Biological Products Co, Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lanzhou Institute of Biological Products Co, Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product and Service

    • Table Seqirus (Foundation Year, Company Profile and etc.)

    • Table Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product and Service

    • Table Protein Sciences Corporation (Foundation Year, Company Profile and etc.)

    • Table Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product and Service

    • Table Astellas Pharma US, Inc (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product and Service

    • Table Sanofi Pasteur (Foundation Year, Company Profile and etc.)

    • Table Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product and Service

    • Table Emergent BioSolutions Inc (Foundation Year, Company Profile and etc.)

    • Table Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product and Service

    • Table Merck Sharp & Dohme Corp (Foundation Year, Company Profile and etc.)

    • Table Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US